• Explore /
  • Poster
  • / A phase I/IIa study to evaluate the safety and efficacy of blood-brain barrier (BBB) opening with the SonoCloud-9 implantable ultrasound device in recurrent glioblastoma patients receiving IV carboplatin.

A phase I/IIa study to evaluate the safety and efficacy of blood-brain barrier (BBB) opening with the SonoCloud-9 implantable ultrasound device in recurrent glioblastoma patients receiving IV carboplatin.

Abstract Poster

Authors

null

Ahmed Idbaih

Inserm U 1127, Cnrs Umr 7225, Sorbonne Universités, UPMC Univ Paris 06 Umr S 1127, Institut Du Cerveau Et De La Moelle Épinière, ICM, Paris, France

Ahmed Idbaih , Francois Ducray , Roger Stupp , Nathalie Baize , Olivier L. Chinot , John Frederick De Groot , Jacques Guyotat , Adam M. Sonabend , Philippe Menei , Henry Dufour , Jeffrey Weinberg , Carole Desseaux , Michael Canney , Charlotte Schmitt , Alexandre Carpentier

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Primary CNS Tumors–Glioma

Clinical Trial Registration Number

NCT03744026

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 2049)

DOI

10.1200/JCO.2021.39.15_suppl.2049

Abstract #

2049

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Adam M. Sonabend

First Author: Ahmed Idbaih

First Author: Dimitris Placantonakis

First Author: Hanmant V. Barkate